Trial · NCT00513305
Adverse events402
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 402
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal distension | Gastrointestinal disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 7 | 33 | 7 |
| other | Abdominal distension | Gastrointestinal disorders | Low-dose Cytarabine Alone | 5 | 33 | 5 |
| other | Abdominal pain | Gastrointestinal disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 7 | 33 | 7 |
| other | Abdominal pain | Gastrointestinal disorders | Low-dose Cytarabine Alone | 4 | 33 | 4 |
| other | Abdominal pain lower | Gastrointestinal disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 2 | 33 | 2 |
| other | Abdominal pain lower | Gastrointestinal disorders | Low-dose Cytarabine Alone | 1 | 33 | 1 |
| other | Abdominal pain upper | Gastrointestinal disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 1 | 33 | 1 |
| other | Abdominal pain upper | Gastrointestinal disorders | Low-dose Cytarabine Alone | 4 | 33 | 4 |
| other | Anaemia | Blood and lymphatic system disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 2 | 33 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Low-dose Cytarabine Alone | 1 | 33 | 1 |
| other | Anorexia | Metabolism and nutrition disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 2 | 33 | 2 |
| other | Anorexia | Metabolism and nutrition disorders | Low-dose Cytarabine Alone | 4 | 33 | 4 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 2 | 33 | 2 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Low-dose Cytarabine Alone | 7 | 33 | 7 |
| other | Asthenia | General disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 7 | 33 | 7 |
| other | Asthenia | General disorders | Low-dose Cytarabine Alone | 9 | 33 | 9 |
| other | Atrial fibrillation | Cardiac disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 0 | 33 | 0 |
| other | Atrial fibrillation | Cardiac disorders | Low-dose Cytarabine Alone | 3 | 33 | 3 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Low-dose Cytarabine Plus Arsenic Trioxide | 6 | 33 | 6 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Low-dose Cytarabine Alone | 3 | 33 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00513305/events